Replimune Group Current Ratio 2011-2026 | REPL

Annual Current Ratio Replimune Group

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.07	4.31	7.08	9.23	12.2	14.7	14.3	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
14.7	4.07	9.41

Quarterly Current Ratio Replimune Group

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
2.71	3.09	3.54	4.07	4.98	4.27	4.93	4.31	4.78	5.78	6.72	7.08	8.16	8.38	-	9.23	10.2	10.9	11.7	12.2	13	5.95	6.37	4.65	4.74	4.92	10.7	9.37	17	40.7	5.1	9.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
40.7	2.71	8.36

Current Ratio of other stocks in the Biotechnology industry

Issuer	Current Ratio	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	1.84	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.02	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	5.42	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	0.995	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	8.96	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	3.86	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	3.59	-	-	$ 40.3 B	USA
Genfit SA GNFT	0.922	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	1.34	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	7.32	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	0.65	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	1.75	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	7.56	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	1.02	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	1.43	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	0.796	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	3.2	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	11.2	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	2.68	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	1.69	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	6.6	$ 50.23	1.6 %	$ 4.52 B	Schweiz
Институт стволовых клеток человека ISKJ	1.04	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	8.41	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	1.88	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	2.69	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	10.4	$ 29.96	2.08 %	$ 1.99 B	USA
Generation Bio Co. GBIO	1.59	-	-	$ 344 M	USA
IMV IMV	0.826	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	10.9	-	-	$ 3.67 B	USA
Akouos AKUS	6.18	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	6.17	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	6.09	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	2.53	-	-	$ 384 M	Britain
Exelixis EXEL	4.16	$ 53.5	1.75 %	$ 14.5 B	USA
Gracell Biotechnologies GRCL	5.9	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	14.4	$ 14.72	-1.51 %	$ 211 M	USA
Advaxis ADXS	3.37	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	1.22	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	12.4	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.79	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	2.59	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	2.76	$ 2.85	-2.06 %	$ 4.69 M	Israel
Enlivex Therapeutics Ltd. ENLV	5.94	$ 0.72	6.9 %	$ 32.9 M	Israel
Aptose Biosciences APTO	0.269	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	2.35	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	2.39	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	2.84	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	5.43	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	1.78	$ 24.59	5.85 %	$ 3.13 B	USA
Allena Pharmaceuticals ALNA	2.19	-	3.16 %	$ 1.9 M	USA